Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
QCOM$165.50-7.69(-4.44%)Qualcomm's Phone Chip Sales Drop 26%: Rapid Earnings Reaction4:50:19 PM ETQCOM$165.50-7.69(-4.44%)Why Qualcomm investors aren't celebrating the Q4 earnings beat4:44:20 PM ETHD$355.78+0.34(+0.10%)Here's What Democrats Taking Back the House and Senate Could Mean for Housing Stocks Like Home Depot and Lowe's4:40:29 PM ETQCOM$165.50-7.69(-4.44%)Qualcomm Revenue Falls as Handset Slowdown Offsets Automotive Gains4:34:00 PM ETQCOM$165.50-7.69(-4.44%)Qualcomm Q4 Highlights: Double Beat, Company Looks Ahead to 'Ramp of our Data Center Business'4:26:13 PM ETARM$189.99-12.69(-6.26%)Arm Shares Slip Despite Q2 Double-Beat: Details4:20:16 PM ETARM$189.99-12.69(-6.26%)Arm Holdings Sales Climb 27% on AI Demand4:20:00 PM ETWMT$129.02-0.15(-0.12%)Walmart (WMT) Stock Is Down 3%. Here's Why I'd Buy in November and Hold for a Decade.4:20:00 PM ETAAPL$349.82+18.18(+5.48%)Apple cements its status as tech's biggest heavyweight with the stock's best day in over a year4:17:00 PM ETAMZN$265.51-0.52(-0.20%)Palmetto Publishing Releases Dr. Nakia Wilson's New Picture Book About a Beloved Uncle With Disabilities4:16:00 PM ETTPL$300.00+12.35(+4.29%)Texas Pacific Land Corporation Announces Third Quarter Results4:15:00 PM ETCOST$1,066.88+20.41(+1.95%)Costco Wholesale Corporation Reports October Sales Results4:15:00 PM ETMETA$633.20+3.20(+0.51%)Meta acquires AI coding startup Conductor4:10:56 PM ETQCOM$165.50-7.69(-4.44%)Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales4:06:59 PM ETAMGN$478.48+17.22(+3.73%)Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story4:06:00 PM ETQCOM$165.50-7.69(-4.44%)Qualcomm forecasts upbeat sales on strength in non-smartphone segments4:04:52 PM ETARM$189.99-12.69(-6.26%)Arm Holdings plc Reports Results for the Second Quarter of the Fiscal Year Ending 20274:04:00 PM ETNVO$41.80-0.38(-0.90%)Novo Nordisk Stock Jumped After Earnings — But Its CEO Won't Give 2027 Guidance. Here's What Investors Should Know4:01:48 PM ETRYTM$109.00-1.68(-1.52%)BRIEF-Astrazeneca Made $10 Billion Offer For Rhythm Pharmaceuticals- WSJ4:01:43 PM ETQCOM$165.50-7.69(-4.44%)Qualcomm Earnings Release Available on Company's Investor Relations Website4:00:15 PM ETAMD$492.05+3.27(+0.67%)Here's What a $1,000 Investment in AMD Could Be Worth by 20304:00:00 PM ETAZN$189.20+5.32(+2.89%)AstraZeneca Made $10 Billion Offer for Rhythm Pharmaceuticals3:57:00 PM ETC$124.74+2.03(+1.65%)Two dead after incident at Citigroup's complex in Florida3:51:37 PM ETGOOG$289.40+2.10(+0.73%)OpenAI Says ChatGPT's Search Volume Is Now a Fifth of Google's3:47:18 PM ET

STIM · NASDAQ

Neuronetics, Inc.

$2.65 +0.38 (+16.74%)

Company overview

Neuronetics, Inc., a commercial-stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers the NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment for adult patients with major depressive disorder. The NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Market cap
$202M
Employees
716
Headquarters
Malvern, PA
Website
neurostar.com
CEO
Jeffrey S. Jones
Listed
June 28, 2018
P/E
-4.91
Dividend yield
0.00%

Company financials

Revenue
$152M
Gross profit
$72.7M
Operating income
-$29.4M
EBITDA
-$26.2M
Net income
-$37.1M
EPS
-$0.54
Total assets
$125M
Total debt
$24.1M
Gross margin
47.96%
Net margin
-24.48%
Earnings yield
-20.38%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

1.021.652.282.913.53
STIM 1D NASDAQ O2.11H2.28L2.11C2.27+0.21 (+10.19%)Vol1.69M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
STIMNeuronetics, Inc. Press release Neuronetics Reports Third Quarter 2026 Financial and Operating Results GlobeNewswire
STIMNeuronetics, Inc. Press release Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call GlobeNewswire
STIMNeuronetics, Inc. Stock news NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System GlobeNewswire
STIMNeuronetics, Inc. Stock news Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript Seeking Alpha
STIMNeuronetics, Inc. Stock news Neuronetics Q2 Earnings Call Highlights MarketBeat
STIMNeuronetics, Inc. Stock news Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates Zacks Investment Research
STIMNeuronetics, Inc. Press release Neuronetics and Jorey Chernett Announce Shared Vision GlobeNewswire
STIMNeuronetics, Inc. Stock news Neuronetics: Top Line Growth, Low Valuation, But Gross Margin Struggles Seeking Alpha
STIMNeuronetics, Inc. Press release Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026 GlobeNewswire
STIMNeuronetics, Inc. Press release Neuronetics Appoints Robert Greene as Senior Vice President Sales GlobeNewswire
STIMNeuronetics, Inc. Press release Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026 GlobeNewswire
STIMNeuronetics, Inc. Press release Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment GlobeNewswire
STIMNeuronetics, Inc. Stock news Neuronetics, Inc. (STIM) Q1 2026 Earnings Call Transcript Seeking Alpha
STIMNeuronetics, Inc. Stock news Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates Zacks Investment Research
STIMNeuronetics, Inc. Press release Neuronetics Reports First Quarter 2026 Financial and Operating Results GlobeNewswire
STIMNeuronetics, Inc. Press release Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
STIMNeuronetics, Inc. Press release Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call GlobeNewswire
STIMNeuronetics, Inc. Press release Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners GlobeNewswire
STIMNeuronetics, Inc. Stock news Neuronetics Announces Chief Financial Officer Transition GlobeNewswire
STIMNeuronetics, Inc. Press release Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business PRNewsWire
See more
FAQ

Questions about Neuronetics, Inc.

What does Neuronetics, Inc. do?
Neuronetics, Inc., a commercial-stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers the NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment for adult patients with major depressive disorder. The NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
What is STIM's market cap?
Neuronetics, Inc. (STIM) is a listed stock with a live quote. The latest market cap on this page is $202M.
Where is Neuronetics, Inc. headquartered?
Neuronetics, Inc. is headquartered in Malvern, PA.
How do I get STIM news from the API?
Call GET /v1/news?tickers=STIM. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does STIM news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for STIM, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the STIM price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs